Related Experiment Video
Updated: May 5, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Next generation biofilm inhibitors for Pseudomonas aeruginosa: Synthesis and rational design approaches
Mahesh S Majik, Prakash T Parvatkar1
1Bio-organic Chemistry Laboratory, CSIR-National Institute of Oceanography, Dona-Paula Goa 403 004, India. majikms@gmail.com.
Abstract:
The bacterial biofilms and the emergence of multiple drug resistance have become a major threat for current medical treatment of nosocomial infections. It has been estimated that about 65-80% of microbial infections in the developed countries are associated with biofilms. Given the prominence of biofilms in infectious diseases, increasing efforts toward the development of small molecules that will modulate bacterial biofilm development and maintenance is on the rise. Till date, marine natural products have shown a tremendous potential as pharma leads and also given new skeletons which would be used as biofilm/QS inhibitors. Medically relevant biofilm forming bacteria such as Pseudomonas aeruginosa which is most frequently isolated bacteria in nosocomial infection is believed to be a model organism for biofilm studies. Hence, in this review, we have highlighted the development of small molecules that inhibit and/or disperse bacterial biofilms of P. aeruginosa in particular. Additionally, the rational design approaches as well as synthetic methodologies along with biological studies has been accounted in this article.
Insights
Marine natural products offer promising small molecules to combat drug-resistant bacterial biofilms, particularly in Pseudomonas aeruginosa, a major cause of hospital-acquired infections.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- Bacterial biofilms contribute significantly to persistent and difficult-to-treat nosocomial infections, affecting 65-80% of microbial infections in developed nations.
- The rise of multiple drug resistance in bacteria necessitates novel therapeutic strategies targeting biofilm formation and maintenance.
- Pseudomonas aeruginosa, a prevalent cause of hospital-acquired infections, serves as a critical model organism for biofilm research.
Purpose of the Study:
- To review the development of small molecules, particularly from marine natural products, that inhibit or disperse bacterial biofilms.
- To highlight strategies for targeting Pseudomonas aeruginosa biofilms.
- To discuss rational design, synthetic methodologies, and biological evaluations of these small molecules.
Main Methods:
- Literature review focusing on marine natural products and their derivatives as biofilm inhibitors.
- Analysis of studies detailing rational design and synthetic approaches for small molecule development.
- Compilation of biological data on the efficacy of these compounds against Pseudomonas aeruginosa biofilms.
Main Results:
- Marine natural products represent a rich source of novel chemical scaffolds with anti-biofilm activity.
- Several small molecules have demonstrated significant potential in inhibiting or dispersing Pseudomonas aeruginosa biofilms.
- Integrated approaches combining rational design, synthesis, and biological testing accelerate the discovery of effective anti-biofilm agents.
Conclusions:
- Small molecules derived from marine natural products are valuable leads for developing new treatments against bacterial biofilms.
- Targeting Pseudomonas aeruginosa biofilms with novel small molecules is crucial for managing nosocomial infections.
- Further research into rational design and synthesis holds promise for advancing anti-biofilm therapies.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial DNA Synthesis

